Core Cap Advisors, LLC Atreca, Inc. Transaction History

Core Cap Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.78 - $1.68 $78 - $168	100 New	100 $0
Q2 2022 Aug 11, 2022	BUY	$1.56 - $3.25 $156 - $325	100 New	100 $0
Q1 2022 Apr 29, 2022	SELL	$1.61 - $5.2 $161 - $520	-100 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.87 - $6.29 $287 - $629	100 New	100 $1,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Core Cap Advisors, LLC with notifications on news.